Idroflog Ophthalmic Solution 15 Single-dose vials

Hydroflog Ophthalmic Solution

Ophthalmic solution containing sodium hyaluronate which, thanks to its properties; muco-mimetic and pseudo-plastic, it is distributed uniformly on the ocular surface forming a protective viscoelastic bandage. The device does not contain preservatives.

Composition
Sodium hyaluronate 2 mg / ml, hydrocortisone sodium phosphate 10 mcg / ml, trisodium citrate, sodium chloride, potassium chloride, magnesium chloride, dibasic sodium phosphate, monobasic sodium phosphate, water for injections.

Modality À of use
Idroflog must be dosed individually according to your condition and according to the recommendations of your ophthalmologist. In general, instill 1-2 drops of the solution into the conjunctival sac of the eye to be treated, 2-4 times a day. The total duration of the treatment is; 2-6 months but must be specifically established by the specialist doctor and in any case under his direct control (a follow-up every 30-45 days is recommended).
How to apply: detach a single vial from the strip. Remove the upper flap by rotating it. Instill 1-2 drops into the conjunctival sac, dropping from above. Idroflog can Ò it can also be used when wearing contact lenses.

Warnings
The product, due to its properties À viscoelastic, at the time of installation it could cause blurred vision. Wait for this effect to stop before driving or operating machinery.
Idroflog È for external use only. It should not be used immediately before the administration of medicinal products for curative purposes, and in the twenty minutes after the application of any topical drug therapy. If during the treatment you feel a worsening of the symptoms, contact at most; soon a doctor. Prolonged use can cause problems: the total duration of treatment must be established by the ophthalmologist. In case È already an inflammatory process is underway, the specialist doctor will decide the appropriate anti-inflammatory therapy in order to restore the physiological conditions of the ocular surface. To reduce the risk of contamination during use, È It is advisable to open the foil bag only in case of immediate subsequent use of the product. Do not allow the tip of the vial to come into direct contact with the fingers, the eye, or any other surface. In rare cases it È observed a slight blurring of vision on instillation, which is due to the viscosity of the solution. During the instillation it may Ò slight burning occurs. This feeling, however, is; destined to disappear. Contact your ophthalmologist if symptoms persist. Compliance with the instructions contained in the package leaflet reduces the risk of undesirable effects. The product is disposable: after the first use discard the vial even if it contains any residual solution.

Format
Pack containing 15 vials of 0.5 ml.